Initial weight loss as a predictor of response to obesity drugs

International Journal of Obesity

Volumn 23, Issue 12, 1999, Pages 1333-1336

  Dhurandhar, N V ^a   Blank, R C ^b   Schumacher, D ^b   Atkinson, Richard L ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Ctr for Nutr and Prev Medicine   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Body weight; Phentermine; Responders; Serum cholesterol; Serum triglycerides

Indexed keywords

FENFLURAMINE; PHENTERMINE;

ADULT; ARTICLE; BODY MASS; DIET; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 0033408532     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801111     Document Type: Article

References (11)

1. 1 Wilson GT. Behavioral treatment of obesity: thirty years and counting. Adv Behav Res Ther 1993; 16: 31-75.
2. 2 Perri MG. Improving maintenance of weight loss following treatment by diet and lifestyle modification. In: Wadden TA, VanItallie TB (eds). Treatment of the Seriously Obese Patient. New York: Guilford Press, 1992, pp 456-477.
3. 3 Wadden TA, Sternberg JA, Letizia KA, Stunkard AJ, Foster GD. Treatment of obesity by very low calorie diet, behavior therapy and their combination: a five-year perspective. Int J Obesity 1989; 13(Suppl 2): S39-S46.
4. 4 Guidance for Treatment of Adult Obesity. Shape-up America/ American Obesity Association, Bethesda, MD, 1996.
5. 5 Atkinson RL, Blank RC, Schumacher D, Dhurandhar NV, Ritch DL. Long-term drug treatment of obesity in a private practice setting. Obesity Res 1997; 5: 578-586.
6. 6 Bray GA. AACE/ACE Obesity Statement. Endocrine Prac 1997; 3: 163-208.
7. 7 Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. Obesity Res 1998; 6(Suppl 2): 51S-209S.
8. 8 World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation on obesity. WHO: Geneva, 1997.
9. 9 Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebvre P, Turner P. International trial of long-term dexfenfluramine in obesity. Lancet 1989; 2: 1142-1145.
10. 10 Lean MEJ. Sibutramine - a review of clinical efficacy, Int J Obes 1997; 21: S30-S36.
11. 11 North American Association for the Study of Obesity, Guidelines for the approval and the use of drugs to treat obesity. Obesity Res 1995; 3: 473-478.